Zobrazeno 1 - 10
of 25
pro vyhledávání: '"S Naoshy"'
Autor:
Sebastian Braun, Pamela B Landsman-Blumberg, S Naoshy, Erika Gleissner, Christine Prosser, Crystal Watson
Publikováno v:
ClinicoEconomics and Outcomes Research: CEOR
Crystal Watson,1 Christine Prosser,2 Sebastian Braun,2 Pamela B Landsman-Blumberg,3 Erika Gleissner,4 Sarah Naoshy1 1Health Economics and Outcomes Research, Global Market Access, Biogen, Cambridge, MA, USA; 2Real World Evidence, Xcenda GmbH, Hanover,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c2e4279231eede80ab483d44d3d11cc
https://pubmed.ncbi.nlm.nih.gov/28203098
https://pubmed.ncbi.nlm.nih.gov/28203098
Publikováno v:
Value in Health. 21:S354-S355
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f42bc6d5a9601599e07c6c9bc3af4057
https://doi.org/10.1016/j.jval.2018.09.2903
https://doi.org/10.1016/j.jval.2018.09.2903
Publikováno v:
Value in Health Regional Issues. 19:S76
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a05452bac7b4b038722eeca8f8026b83
https://doi.org/10.1016/j.vhri.2019.08.420
https://doi.org/10.1016/j.vhri.2019.08.420
Autor:
S. Naoshy, Daniel Mikol, Jennifer Petrillo, Jeremy Hobart, Sophie Cleanthous, Stefan J. Cano, D Steiner, Patrick Marquis, Crystal Watson
Publikováno v:
Value in Health. 18(7)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bcdead191180e179b96984d81b3bcdbf
Publikováno v:
Value in Health. 18(7)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27d0e3d23e0e529bb5a71cbd93ceef58
Autor:
Stefan J. Cano, Jennifer Petrillo, S. Naoshy, Crystal Watson, Yi Chen, D Steiner, Sophie Cleanthous, Daniel Mikol, Patrick Marquis, Jeremy Hobart
Publikováno v:
Value in Health. 18(3)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3e19e1ed32b6a9243e4d840b35eec38
Publikováno v:
Value in Health. 18(3)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a348129eb2c48e673ae34b6a3f21b71
Autor:
C, Pericay, C, Frías, A, Abad, M J, Lamas, M, Echave, I, Oyagüez, M, Rubio, E, Giménez, S, Naoshy, F, Joulain
Publikováno v:
Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria. 38(4)
To estimate the incremental cost per life-year gained (LYG) of aflibercept in combination with FOLFIRI as second-line treatment in metastatic colorectal cancer (mCRC) patients previously treated with oxaliplatin.Based on clinical trial VELOUR results
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e63b6d63de1dc84557c69b25db36d0aa
https://pubmed.ncbi.nlm.nih.gov/25137165
https://pubmed.ncbi.nlm.nih.gov/25137165
Autor:
Usman Iqbal, F. Joulain, S. H. Goey, N. Muszbek, D.R. Ferry, S. Naoshy, Dara Stein, K. A. Payne
Publikováno v:
International journal of colorectal disease. 29(10)
This study aimed to elicit EuroQol Quality of Life 5-Dimensions (EQ-5D) utility values from patients with second-line metastatic colorectal cancer (mCRC) pre- and post-progression. A cross-sectional study was conducted in five hospitals in the Nether
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72fc1ed04ad26676147ddb441ac19b1a
https://pubmed.ncbi.nlm.nih.gov/25080148
https://pubmed.ncbi.nlm.nih.gov/25080148
Autor:
Daniel Mikol, Jeremy Hobart, Sophie Cleanthous, Patrick Marquis, S. Naoshy, Crystal Watson, D Steiner, Stefan J. Cano, Jennifer Petrillo
Publikováno v:
Value in Health. 18:A709-A710
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe16b79106cc5917ccabf8ac4e27ff37
https://doi.org/10.1016/j.jval.2015.09.2670
https://doi.org/10.1016/j.jval.2015.09.2670